John Armitage
Egerton Capital
John Armitage HCA Healthcare, Inc stake
total: 222
Egerton Capital HCA trades
- Total transactions:
- 2
- New positions:
- 1
- Sold out:
- 1
- Held since:
- 2014 Q3
- Held for:
- 1 quarter
- Latest activity:
- 2014 Q4
According to 2026 Q2 report, John Armitage doesn't hold any HCA Healthcare, Inc (HCA) shares. To date, the estimated cost basis is nearly $70.52 for "buy" trades and estimated average "sell" price is $70.52. Egerton Capital first purchased HCA in 2014 Q3, initially acquiring about 1.27M shares. Since the initial investment in HCA Healthcare, Inc (HCA), Egerton Capital has made 1 more transaction.
When did John Armitage sell HCA Healthcare, Inc (HCA)?
John Armitage sold off the entire HCA Healthcare, Inc (HCA) position in 2014 Q4.
When did John Armitage buy HCA Healthcare, Inc (HCA)?
John Armitage first invested in HCA Healthcare, Inc (HCA) in 2014 Q3 at the reported quarter-end price of $70.52 per share.
What's the cost basis of Egerton Capital's HCA stake?
The estimated cost basis for HCA Healthcare, Inc (HCA) stake is around $70.52 per share. This represents their average reported price* across all buy transactions
Estimated cost basis*
- Weighted AVG buy price:
- $70.52
- Weighted AVG sell price:
- $70.52
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Reported price: this doesn't represent the actual buy or sell price. It is the split-adjusted price of the security as of the last day of the reported period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
* Estimated cost basis: based on "Reported price*" (not earlier than 2013 Q2). Calculation starts from the latest "new buy" activity to the latest "close out" activity (if any).
* Value or Price: If the security is completely sold out, we show the reported value (or price) prior to the actual period.
* New buy or own: this means there is no earlier reporting (for us or in general). So we can't know if the actual purchase of the security happened at the reported period or earlier.